Eventide Asset Management’s Sage Therapeutics SAGE Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-790,000	Closed	-$22.7M	–	137
2020 Q1	$22.7M	Hold	790,000	–	–	0.73%	52
2019 Q4	$57M	Hold	790,000	–	–	1.61%	18
2019 Q3	$111M	Buy	790,000 +35,000	+5%	+$4.91M	3.66%	3
2019 Q2	$138M	Sell	755,000 -50,000	-6%	-$9.15M	4.2%	3
2019 Q1	$128M	Sell	805,000 -131,000	-14%	-$20.8M	4.41%	2
2018 Q4	$89.7M	Buy	936,000 +442,000	+89%	+$42.3M	3.97%	3
2018 Q3	$69.8M	Buy	494,000 +124,000	+34%	+$17.5M	2.56%	5
2018 Q2	$57.9M	Buy	370,000 +120,000	+48%	+$18.8M	2.4%	4
2018 Q1	$40.3M	Buy	250,000 +65,400	+35%	+$10.5M	1.89%	12
2017 Q4	$30.4M	Buy	184,600 +25,600	+16%	+$4.22M	1.59%	21
2017 Q3	$9.91M	Buy	159,000 +78,000	+96%	+$4.86M	0.56%	60
2017 Q2	$6.45M	Hold	81,000	–	–	0.4%	63
2017 Q1	$5.76M	Sell	81,000 -89,000	-52%	-$6.33M	0.38%	69
2016 Q4	$8.68M	Hold	170,000	–	–	0.56%	57
2016 Q3	$7.83M	Hold	170,000	–	–	0.48%	59
2016 Q2	$5.12M	Hold	170,000	–	–	0.31%	73
2016 Q1	$5.45M	Buy	170,000 +44,100	+35%	+$1.41M	0.3%	72
2015 Q4	$7.34M	Buy	125,900 +6,700	+6%	+$391K	0.37%	66
2015 Q3	$5.05M	Buy	119,200 +79,000	+197%	+$3.34M	0.29%	73
2015 Q2	$2.94M	Hold	40,200	–	–	0.16%	90
2015 Q1	$2.02M	Hold	40,200	–	–	0.15%	94
2014 Q4	$1.47M	Hold	40,200	–	–	0.16%	88
2014 Q3	$1.27M	Buy	+40,200	New	+$1.27M	0.18%	86